Skip to main content
. 2022 Feb 12;34(7):1511–1528. doi: 10.1007/s40520-022-02079-y

Table 2.

The characteristics of the sample population for included studies

Authors & year of publication Sample characteristics
Sample size Age range (mean) % Female (n =) Chronic disease
Intervention Comparison Intervention Comparison
Jang et al. 2018 [33] 22 (Control = 11) 66–70 (68.6) 68–76 (72.5) 17% (3) 45% (5) None reported—although included prefrail group screened using the cardiovascular health frailty phenotype criteria
Jindo et al. 2016 [34] 68 (Control = 34) 67–73 (70.0) 66–74 (70.0) 91.2% (31) 91.2% (31) None reported—ambulant and living independently
Jindo et al. 2017 [35] 46 66.6–73.6 (70.1) N/A 87% (40) N/A None reported—ambulant and living independently
Lin et al. 2006 [36] 88 65 + (upper range and mean not specified) N/A 68.2% (60) N/A Yes, 68.2% reported at least 1 comorbid condition (not specified)
McMahon et al. 2016 [37] 30 (Control = 14) 78.9–88.3 (83.6) 78.9–88.3 (83.6) 93.3% (15) 93.3% (13) None reported
Muscari et al. 2010 [38] 120 (Control = 60) 66.3–71.3 (68.8) 66.8–72.4 (69.6) 47.7% (28) 50% (30) 5% COPD, 73.3% Hypertension, 60.8% Hypercholesterolaemia
Okumiya et al. 1996 [39] 42 (Control = 21) 75–87 (78.8) 75–87 (78.8) 57.1% (12) 57.1% (12) None reported
Snapp et al. 2009 [40] 19 (Control = 9)  > 65 (85)  > 65 (85) 80% (8) 100% (9) None reported—Participants living at an assisted living facility or an independent living facility
Sowle et al. 2017 [41] 265 65–85 +  N/A 83.4% (221) N/A None reported—ambulant and living independently
Tarazona-Santabalbina et al. 2016 [42] 100 (Control = 49) 76.1–83.3 (79.7) 76.6–84 (80.3) 56.9% (29) 51% (25) 77% Hypertension, 46% Hyperlipidaemia, 8% COPD
Wang et al. 2014 [43] 520 (Group 1* = 431) 68.53–80.81 (74.67) 71.45–82.01 (76.73) 65% (280) 68.5% (61) None reported
Yates and Dunnagan 2001 [27] 37 (Control = 19) 67–90 (76) 69–88 (78) 72.2% (13) 68.4% (13) None reported

*Group 1 = nursing home group intervention vs Group 2 = community-dwelling intervention